Diabetes Care Devices - Germany | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in Germany is anticipated to reach US$1.39bn in 2024.
This revenue is projected to demonstrate an annual growth rate (CAGR 2024-2029) of 12.23%, leading to a market volume of US$2.47bn by 2029.
In a global context, the highest revenue is expected to be produced the United States, with a figure of US$11.71bn in 2024.
Germany is witnessing a significant shift towards advanced diabetes care devices, driven by increasing healthcare investments and a growing emphasis on patient-centered solutions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market within the Medical Devices sector in Germany is witnessing considerable growth, fueled by advancing technology, increasing prevalence of diabetes, and heightened consumer awareness about the importance of effective glucose management solutions.

Customer preferences: Consumers in Germany are increasingly prioritizing personalized diabetes management solutions, leading to a rise in demand for smart insulin pens and continuous glucose monitors that offer real-time data and insights. The growing trend of health-conscious living, particularly among younger demographics, is driving interest in integrated diabetes care apps that combine lifestyle tracking with glucose monitoring. Additionally, there is a notable shift towards sustainability, prompting consumers to favor eco-friendly and reusable diabetes devices that align with their environmental values.

Trends in the market: In Germany, the Diabetes Care Devices Market is experiencing a significant shift towards personalized and integrated solutions, driven by consumer demand for smart insulin pens and continuous glucose monitoring systems that provide real-time insights. This trend is particularly pronounced among younger populations who prioritize health-conscious lifestyles and seek integrated diabetes care apps that merge glucose tracking with overall wellness metrics. Moreover, sustainability is becoming a key factor, as consumers increasingly opt for eco-friendly, reusable diabetes devices that reflect their environmental commitments. This evolving landscape presents vital implications for industry stakeholders, encouraging innovation, collaboration, and a focus on patient-centric solutions.

Local special circumstances: In Germany, the Diabetes Care Devices Market is shaped by a robust healthcare infrastructure and a strong emphasis on innovation, fueled by stringent regulatory standards that prioritize patient safety and efficacy. The country's cultural focus on health and wellness drives demand for advanced diabetes management solutions, particularly among tech-savvy individuals. Additionally, Germany’s commitment to sustainability influences consumer preferences for eco-friendly devices, while the aging population necessitates more integrated care approaches, further shaping the market dynamics.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Germany is significantly influenced by macroeconomic factors such as national economic health, consumer spending power, and investment in healthcare innovation. Germany's strong economy, characterized by low unemployment and robust industrial output, supports increased healthcare expenditures, enabling consumers to invest in advanced diabetes management technologies. Furthermore, favorable fiscal policies and public health funding facilitate research and development in medical devices. Additionally, the rising prevalence of diabetes and the aging population are driving demand for innovative solutions, ensuring that the market remains dynamic and responsive to evolving healthcare needs.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.